Tag: Concentriq

All

Proscia and Owkin Partner on MSI Screening for Colorectal Cancer Using AI

Proscia and Owkin announced a partnership to integrate AI-driven MSI screening technology, expanding access to colorectal cancer diagnostics.

Proscia Expands Concentriq Platform to Accelerate AI-Driven Pathology
Proscia Strengthens Clinical Customer Base, Showcases AI-Powered Pathology Innovations
Proscia And Nucleai Will Broaden Access to AI Predictive Biomarkers
Proscia Receives FDA 510(k) Clearance For Concentriq AP-Dx
Proscia Achieves ISO 27001 Security Certification
Proscia, DoMore Diagnostics Partner for Improved Colorectal Cancer Treatment
Mindpeak, Proscia Partner to Improve Cancer Diagnosis with AI
Spectrum Healthcare Partners Taps Proscia to Democratize Cancer Diagnosis
PathGroup Expands Proscia Partnership for Cancer Diagnostics

All

Proscia Upgrades Concentriq for Modern Diagnostic Pathology

The latest version of Concentriq is designed to deliver a natural, microscope-like viewing experience from within a robust digital pathology environment for multi-site and remote operations.

Improved Prostate Cancer Diagnosis with AI-powered Workflows
LabPON Adopts Proscia’s Concentriq to Meet Demand for Cancer Diagnostic Services
Proscia’s Concentriq Deployed by NASA’s JPL for Biomedical Research
Proscia’s Concentriq Selected for Joint Pathology Center
Proscia Introduces Third Generation of Concentriq Platform
Proscia, UMC Utrecht Establish Center of Excellence for Computational Pathology

All

Proscia Achieves MDSAP Certification

This certification accelerates the company’s expansion into the diagnostic pathology market.

Digital Pathology Software for Remote Use
Proscia Granted US Patent for AI-Powered Dermatopathology

Tag: Concentriq

All

Proscia and Owkin Partner on MSI Screening for Colorectal Cancer Using AI

Proscia Expands Concentriq Platform to Accelerate AI-Driven Pathology

Proscia Strengthens Clinical Customer Base, Showcases AI-Powered Pathology Innovations

Proscia And Nucleai Will Broaden Access to AI Predictive Biomarkers

Proscia Receives FDA 510(k) Clearance For Concentriq AP-Dx

Proscia Achieves ISO 27001 Security Certification

Proscia, DoMore Diagnostics Partner for Improved Colorectal Cancer Treatment

Mindpeak, Proscia Partner to Improve Cancer Diagnosis with AI

Spectrum Healthcare Partners Taps Proscia to Democratize Cancer Diagnosis

PathGroup Expands Proscia Partnership for Cancer Diagnostics

All

Proscia Upgrades Concentriq for Modern Diagnostic Pathology

Improved Prostate Cancer Diagnosis with AI-powered Workflows

LabPON Adopts Proscia’s Concentriq to Meet Demand for Cancer Diagnostic Services

Proscia’s Concentriq Deployed by NASA’s JPL for Biomedical Research

Proscia’s Concentriq Selected for Joint Pathology Center

Proscia Introduces Third Generation of Concentriq Platform

Proscia, UMC Utrecht Establish Center of Excellence for Computational Pathology

All

Proscia Achieves MDSAP Certification

Digital Pathology Software for Remote Use

Proscia Granted US Patent for AI-Powered Dermatopathology

Sorry, No Posts Found

Clinical Lab Products

Our Parent Company

Key Resources

Helpful Links